Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: Dr Terry and colleagues recently
demonstrated an association between aspirin use and a reduced incidence of
hormone receptor–positive breast cancer.1 We
are concerned about how the implied relative change of risk (a 26% decrease;
OR, 0.74; 95% CI, 0.60-0.93) is presented to the public without addressing
the absolute risk reduction.
Woloshin S, Schwartz LM. Association of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk. JAMA. 2004;292(12):1426-1427. doi:10.1001/jama.292.12.1426-b